Fiscal year 2026 rare cancers research program support for meeting programmatic and administrative support services.

Active Awarded Last action

Contract number
HT942726FE087
Awardee
Awarding agency
Obligated
$201,124

Award facts

Contract value 51% obligated
$396,086.53 Current and potential, with all options
Completion date 33% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
R408 Support- Professional: Program Management/Support
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Reston, VA 20190, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a delivery order to Leidos, Inc. on June 24, 2026, with a ceiling value of $396,086.53 for Fiscal Year 2026 Rare Cancers Research Program support providing programmatic and administrative support services. The order is priced on a cost-plus-fixed-fee basis and carries an ultimate completion date of June 23, 2027.

Place of performance is Reston, VA 20190. No set-aside applies to this delivery order.

Quick answers

Who was awarded contract HT942726FE087?

HT942726FE087 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on June 24, 2026.

How much is contract HT942726FE087 worth?

The government has obligated $201,124 on HT942726FE087. Its current value, with exercised options, is $396,087.

Is contract HT942726FE087 an order under another contract?

Yes. HT942726FE087 is a delivery order under HT942523D0002, an indefinite delivery contract.

Was contract HT942726FE087 competed?

The extent of competition for HT942726FE087 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award